Quest to sell Thermo Fisher's peanut allergy diagnostic

Thermo Fisher Scientific ($TMO) has inked a distribution deal with Quest Diagnostics ($DGX) for its peanut allergy tests. Neither side is disclosing financial terms, but the non-exclusive deal calls for Quest to market the company's ImmunoCAP Peanut Component blood test to physicians across the country. The arrangement also allows both companies to co-market ImmunoCAP test services offered at Quest clinical laboratories. Release

BD&L Summit

Deal-Making Insights for the Life Sciences Industry

Bringing together key deal-makers and serving as an open forum for cross-functional business development and legal teams to share valuable insights and actionable strategies on successfully managing alliances, licensing agreements, and M&A deals.